-
Nov 21, 2024 | 
nature.com | Qian Shi
AbstractEpithelial–mesenchymal transition (EMT) of retinal pigment epithelial (RPE) cells plays key roles in the pathogenesis of multiple vitreoretinal diseases, leading to profound and permanent vision loss. Circular RNAs (circRNAs) are widespread and functional endogenous RNAs that could regulate gene expression in eukaryotes. The functions of circRNAs in mediating EMT has been reported in several diseases.
-
Jun 19, 2024 | 
onlinelibrary.wiley.com | Qian Shi |Tiejun Wang
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adfm202404848-sup-0001-SuppMat.docx1.7 MB Supporting Information References 1, , Prog. Polym. Sci. 2017, 76, 65. 2, , , , , , , , , , , , Nature 2020, 583, 542. 3a) , , , , , , , , , , , , Nature 2018, 557, 223; b) , , , , , ACS Sustainable Chem. Eng. 2018, 6, 9189. 4a) , , , , , Chem. Rev.
-
Apr 27, 2024 | 
medrxiv.org | Janet Alvarez |Qian Shi |Arvind Dasari |Julio Garcia-Aguilar
JGA claims ownership/equity interests for Intuitive Surgical Inc.
-
Jan 19, 2024 | 
dialnet.unirioja.es | Qian Shi
Analysis of Factors Affecting Seasonal Affective Disorder in Public Environment and College Football Players Based on Computerized Neural Network Light Therapy[1]University of Queensland, St. Lucia, AustraliaLocalización: Revista de psicología del deporte, ISSN 1132-239X, ISSN-e 1988-5636, Vol. 32, Nº 4, 2023, págs.
-
Dec 12, 2023 | 
sciencedirect.com | Qian Shi |Miao Li |Shukur Wasman Smail |Arash Abdolmaleki
IntroductionOA is still a major problem affecting the quality of life of middle-aged and older people worldwide, with the gradual aging of the population [1]. The socio-economic burden is still very high for many families, particularly disability due to osteoarthritis [2]. Osteoarthritis is a degenerative disease characterized by wear and tear of the articular cartilage and synovial inflammation, primarily in the knee joint [3].
-
Dec 10, 2023 | 
dovepress.com | Xue Ding |Qian Shi |Chao Xiao
Back to Journals » Psychology Research and Behavior Management » Volume 17 Authors Ding X, Shi Q, Xiao C Received 10 December 2023 Accepted for publication 26 March 2024 Published 6 April 2024 Volume 2024:17 Pages 1515—1531 DOI https://doi.org/10.2147/PRBM.S454292 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Gabriela Topa Xue Ding,1 Qian Shi,2 Chao Xiao2 1School of Financial Technology, Shanghai Lixin University...
-
Sep 1, 2023 | 
acsjournals.onlinelibrary.wiley.com | Justin Brown |Chao Ma |Qian Shi |Tyler J. Zemla
CONFLICT OF INTEREST STATEMENT Justin C. Brown reports receiving grants from the National Institutes of Health, American Institute for Cancer Research, and Cancer Research UK paid to his institution and being a consultant for Novo Nordisk.
-
Aug 11, 2023 | 
mdpi.com | Chenyu Liu |Qian Shi
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticleby and * School of Economics and Management, Tongji University, Shanghai 200092, China*Author to whom correspondence should be addressed.
-
Jun 15, 2023 | 
jamanetwork.com | Josh McGovern |Ross Dolan |Donald McMillan |Qian Shi
Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer En Cheng, MD, PhD; Qian Shi, PhD; Anthony F. Shields, MD, PhD; Andrew B. Nixon, PhD, MBA; Ardaman P. Shergill, MD; Chao Ma, MS; Katherine A. Guthrie, PhD; Felix Couture, MD; Philip Kuebler, MD; Pankaj Kumar, MD; Benjamin Tan, MD; Smitha S. Krishnamurthi, MD; Kimmie Ng, MD, MPH; Eileen M. O’Reilly, MD; Justin C. Brown, PhD; Philip A. Philip, MD, PhD; Bette J. Caan, DrPH; Elizabeth M.
-
Mar 6, 2023 | 
bjsm.bmj.com | Justin Brown |Chao Ma |Qian Shi |Donna Niedzwiecki
MethodStudy designThe Cancer and Leukemia Group B (now part of the Alliance for Clinical Trials in Oncology) and Southwest Oncology Group (SWOG) trial 80 702 was a phase III double-blinded randomised study that used a 2×2 factorial design to test the primary hypothesis of the superiority of celecoxib compared with placebo and the secondary hypothesis of the non-inferiority of 3 months compared with 6 months of chemotherapy.
